Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of CGRP receptor antagonists in neuroprotection and neurological disorders

Use of CGRP receptor antagonists in neuroprotection and neurological disorders

US Patent 12103951 · Granted Oct 1, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of CGRP receptor antagonists in neuroprotection and neurological disorders2022
Peptide antagonists of the calcitonin CGRP family of peptide hormones and their 2019
CGRP agonist peptides2018
Freight removal regulation apparatus2017
Engineered polypeptides having enhanced duration of action2017
Hybrid polypeptides with selectable properties2016
GLP-1 receptor agonist compounds having stabilized regions2015
Peptide antagonists of the calcitonin CGRP family of peptide hormones and their 2015
GIP analog and hybrid polypeptides with selectable properties2015
GIP and exendin hybrid polypeptides2014
Peptide-peptidase inhibitor conjugates and methods of using same2014
Hybrid polypeptides with selectable properties2014